Mirum’s LIVMARLI Now FDA Approved in Tablet Formulation
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: MIRM) | Delayed: 80.39 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $80.39 | 52 Week High | $ | |||
| Open | $80.39 | 52 Week Low | $ | |||
| Day High | $80.39 | P/E | N/A | |||
| Day Low | $80.39 | EPS | $ | |||
| Volume | 49 | |||||
